Which has higher valuation and earnings, CCLD or MDXH?

CareCloud has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.80 $10.80M $0.11 20.73 MDxHealth $110.97M 0.22 -$33.52M -$0.65 N/A

Is CCLD or MDXH more profitable?

CareCloud has a net margin of 7.87% compared to MDxHealth's net margin of -29.90%. CareCloud's return on equity of 24.05% beat MDxHealth's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% MDxHealth -29.90% N/A -22.51%

Is ZEPP or MDXH more profitable?

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% MDxHealth -29.90% N/A -22.51%

Is PIII or MDXH more profitable?

P3 Health Partners has a net margin of -8.57% compared to MDxHealth's net margin of -29.90%. Company Net Margins Return on Equity Return on Assets P3 Health Partners -8.57% N/A -19.99% MDxHealth -29.90% N/A -22.51%

Which has preferable earnings & valuation, MDXH or NYXH?

MDxHealth has higher revenue and earnings than Nyxoah. MDxHealth is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MDxHealth $110.97M 0.22 -$33.52M -$0.65 N/A Nyxoah $11.33M 5.71 -$101.92M -$2.48 N/A

Is MDXH or NYXH more profitable?

MDxHealth has a net margin of -29.90% compared to Nyxoah's net margin of -543.21%. MDxHealth's return on equity of 0.00% beat Nyxoah's return on equity. Company Net Margins Return on Equity Return on Assets MDxHealth -29.90% N/A -22.51% Nyxoah -543.21% -163.73% -80.24%

MDxHealth (MDXH) Competitors

$0.49 -0.01 (-1.03%)

Closing price 07/9/2026 04:00 PM Eastern

Extended Trading

$0.49 0.00 (-0.59%)

As of 04:00 AM Eastern

Compare

MDXH vs. OM, CCLD, ZEPP, PIII, and NYXH

Should you buy MDxHealth stock or one of its competitors? MarketBeat compares MDxHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MDxHealth include Outset Medical (OM), CareCloud (CCLD), Zepp Health (ZEPP), P3 Health Partners (PIII), and Nyxoah (NYXH). These companies are all part of the "medical info sys" industry.

How does MDxHealth compare to Outset Medical?

Outset Medical (NASDAQ:OM) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

MDxHealth has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.69	-$81.65M	-$4.16	N/A
MDxHealth	$110.97M	0.22	-$33.52M	-$0.65	N/A

MDxHealth has a net margin of -29.90% compared to Outset Medical's net margin of -63.65%. MDxHealth's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
MDxHealth	-29.90%	N/A	-22.51%

Outset Medical presently has a consensus target price of $10.00, indicating a potential upside of 124.72%. MDxHealth has a consensus target price of $4.63, indicating a potential upside of 844.07%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Outset Medical has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

In the previous week, Outset Medical had 1 more articles in the media than MDxHealth. MarketBeat recorded 1 mentions for Outset Medical and 0 mentions for MDxHealth. Outset Medical's average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score.

Company	Overall Sentiment
Outset Medical	Neutral
MDxHealth	Neutral

Summary

MDxHealth beats Outset Medical on 9 of the 13 factors compared between the two stocks.

How does MDxHealth compare to CareCloud?

CareCloud (NASDAQ:CCLD) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

CareCloud presently has a consensus price target of $3.25, indicating a potential upside of 42.54%. MDxHealth has a consensus price target of $4.63, indicating a potential upside of 844.07%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts clearly believe MDxHealth is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, CareCloud's average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score.

Company	Overall Sentiment
CareCloud	Neutral
MDxHealth	Neutral

CareCloud has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.80	$10.80M	$0.11	20.73
MDxHealth	$110.97M	0.22	-$33.52M	-$0.65	N/A

CareCloud has a beta of 1.52, indicating that its share price is 52% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

CareCloud has a net margin of 7.87% compared to MDxHealth's net margin of -29.90%. CareCloud's return on equity of 24.05% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
MDxHealth	-29.90%	N/A	-22.51%

10.2% of CareCloud shares are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

CareCloud beats MDxHealth on 11 of the 14 factors compared between the two stocks.

How does MDxHealth compare to Zepp Health?

Zepp Health (NYSE:ZEPP) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

In the previous week, Zepp Health had 3 more articles in the media than MDxHealth. MarketBeat recorded 3 mentions for Zepp Health and 0 mentions for MDxHealth. Zepp Health's average media sentiment score of 0.18 beat MDxHealth's score of 0.00 indicating that Zepp Health is being referred to more favorably in the media.

Company	Overall Sentiment
Zepp Health	Neutral
MDxHealth	Neutral

Zepp Health has a beta of 1.83, indicating that its stock price is 83% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

Zepp Health currently has a consensus target price of $56.28, indicating a potential upside of 938.76%. MDxHealth has a consensus target price of $4.63, indicating a potential upside of 844.07%. Given Zepp Health's higher probable upside, analysts plainly believe Zepp Health is more favorable than MDxHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

52.6% of Zepp Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

MDxHealth has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.31	-$40.07M	-$2.52	N/A
MDxHealth	$110.97M	0.22	-$33.52M	-$0.65	N/A

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
MDxHealth	-29.90%	N/A	-22.51%

Summary

Zepp Health beats MDxHealth on 10 of the 16 factors compared between the two stocks.

How does MDxHealth compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

MDxHealth has lower revenue, but higher earnings than P3 Health Partners. MDxHealth is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A
MDxHealth	$110.97M	0.22	-$33.52M	-$0.65	N/A

P3 Health Partners currently has a consensus price target of $14.00, suggesting a potential upside of 41.99%. MDxHealth has a consensus price target of $4.63, suggesting a potential upside of 844.07%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

7.8% of P3 Health Partners shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by company insiders. Comparatively, 1.7% of MDxHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

P3 Health Partners has a net margin of -8.57% compared to MDxHealth's net margin of -29.90%.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-8.57%	N/A	-19.99%
MDxHealth	-29.90%	N/A	-22.51%

In the previous week, P3 Health Partners had 1 more articles in the media than MDxHealth. MarketBeat recorded 1 mentions for P3 Health Partners and 0 mentions for MDxHealth. P3 Health Partners' average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score.

Company	Overall Sentiment
P3 Health Partners	Neutral
MDxHealth	Neutral

P3 Health Partners has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

Summary

P3 Health Partners beats MDxHealth on 8 of the 14 factors compared between the two stocks.

How does MDxHealth compare to Nyxoah?

MDxHealth (NASDAQ:MDXH) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

MDxHealth presently has a consensus price target of $4.63, indicating a potential upside of 844.07%. Nyxoah has a consensus price target of $5.96, indicating a potential upside of 257.04%. Given MDxHealth's stronger consensus rating and higher probable upside, equities research analysts plainly believe MDxHealth is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

MDxHealth has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market. Comparatively, Nyxoah has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market.

MDxHealth has a net margin of -29.90% compared to Nyxoah's net margin of -543.21%. MDxHealth's return on equity of 0.00% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-29.90%	N/A	-22.51%
Nyxoah	-543.21%	-163.73%	-80.24%

In the previous week, Nyxoah had 5 more articles in the media than MDxHealth. MarketBeat recorded 5 mentions for Nyxoah and 0 mentions for MDxHealth. Nyxoah's average media sentiment score of 0.14 beat MDxHealth's score of 0.00 indicating that Nyxoah is being referred to more favorably in the news media.

Company	Overall Sentiment
MDxHealth	Neutral
Nyxoah	Neutral

MDxHealth has higher revenue and earnings than Nyxoah. MDxHealth is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$110.97M	0.22	-$33.52M	-$0.65	N/A
Nyxoah	$11.33M	5.71	-$101.92M	-$2.48	N/A

Summary

MDxHealth beats Nyxoah on 9 of the 14 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDXH vs. The Competition

Export

Metric	MDxHealth	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$24.50M	$1.80B	$6.93B	$12.49B
Dividend Yield	N/A	N/A	2.68%	7.79%
P/E Ratio	-0.75	76.68	27.37	24.61
Price / Sales	0.22	7.63	551.56	113.75
Price / Cash	N/A	26.04	48.45	59.17
Price / Book	-2.04	5.75	11.02	6.46
Net Income	-$33.52M	-$54.76M	$3.57B	$331.60M
7 Day Performance	2.81%	2.27%	0.42%	0.33%
1 Month Performance	-10.77%	6.98%	6.55%	2.51%
1 Year Performance	-77.53%	-1.60%	29.66%	21.59%

MDxHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDXH MDxHealth	3.0812 of 5 stars	$0.49 -1.0%	$4.63 +844.1%	-77.7%	$24.50M	$110.97M	N/A	300
OM Outset Medical	2.3285 of 5 stars	$4.79 -5.7%	$10.00 +108.8%	-78.3%	$94.17M	$119.48M	N/A	520
CCLD CareCloud	3.5931 of 5 stars	$2.14 -3.2%	$3.25 +51.9%	-5.0%	$93.91M	$120.50M	19.46	3,650
ZEPP Zepp Health	2.3808 of 5 stars	$4.96 -9.4%	$56.28 +1,035.6%	-1.7%	$80.30M	$258.90M	N/A	1,230	Gap Up
PIII P3 Health Partners	2.3836 of 5 stars	$10.53 +2.3%	$14.00 +33.0%	+54.1%	$74.55M	$1.46B	N/A	500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDXH) was last updated on 7/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MDxHealth (MDXH) Competitors

MDXH vs. OM, CCLD, ZEPP, PIII, and NYXH

How does MDxHealth compare to Outset Medical?

Summary

How does MDxHealth compare to CareCloud?

Summary

How does MDxHealth compare to Zepp Health?

Summary

How does MDxHealth compare to P3 Health Partners?

Summary

How does MDxHealth compare to Nyxoah?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MDxHealth (MDXH) Competitors

MDXH vs. OM, CCLD, ZEPP, PIII, and NYXH

How does MDxHealth compare to Outset Medical?

Which has better valuation and earnings, OM or MDXH?

Is OM or MDXH more profitable?

Do analysts prefer OM or MDXH?

Which has more volatility and risk, OM or MDXH?

Does the media refer more to OM or MDXH?

Summary

How does MDxHealth compare to CareCloud?

Do analysts recommend CCLD or MDXH?

Does the media favor CCLD or MDXH?

Which has higher valuation and earnings, CCLD or MDXH?

Which has more risk & volatility, CCLD or MDXH?

Is CCLD or MDXH more profitable?

Do institutionals and insiders believe in CCLD or MDXH?

Summary

How does MDxHealth compare to Zepp Health?

Does the media favor ZEPP or MDXH?

Which has more volatility & risk, ZEPP or MDXH?

Do analysts recommend ZEPP or MDXH?

Do insiders and institutionals believe in ZEPP or MDXH?

Which has preferable earnings & valuation, ZEPP or MDXH?

Is ZEPP or MDXH more profitable?

Summary

How does MDxHealth compare to P3 Health Partners?

Which has better earnings & valuation, PIII or MDXH?

Do analysts prefer PIII or MDXH?

Do insiders & institutionals have more ownership in PIII or MDXH?

Is PIII or MDXH more profitable?

Does the media favor PIII or MDXH?

Which has more volatility and risk, PIII or MDXH?

Summary

How does MDxHealth compare to Nyxoah?

Do analysts prefer MDXH or NYXH?

Which has more volatility & risk, MDXH or NYXH?

Is MDXH or NYXH more profitable?

Does the media refer more to MDXH or NYXH?

Which has preferable earnings & valuation, MDXH or NYXH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools